Skip to content

Exercise Training and Vitamin D Metabolism

The Impact of Hybrid-type High-intensity Interval Training on Vitamin D Metabolism in Adults With Overweight/Obesity

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07300332
Acronym
Hybri-D
Enrollment
30
Registered
2025-12-23
Start date
2025-11-10
Completion date
2026-07-20
Last updated
2026-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity & Overweight, Vitamin D

Keywords

overweight, obesity, vitamin D, 25-hydroxyvitamin D, high-intensity interval training

Brief summary

The prevalence of Vitamin D deficiency is significantly higher in adults with overweight/obesity compared to those with normal body mass index (BMI). The "entrapment" of Vitamin D in adipose tissue due to impaired lipolytic stimulation and/or adipose tissue dysfunction has been proposed as the driving mechanism. Exercise training has been proposed as a promising strategy to increase mobilization of Vitamin D from adipose tissue, given its well described role in stimulating lipolysis. Indeed, a recent study revealed that participation in moderate-intensity cardiovascular type exercise over winter can mitigate the decline in 25-hydroxyvitamin D \[25(OH)D\] in adults with overweight/obesity, independent of weight loss. The aim of this study is to investigate the impact of hybrid-type high-intensity interval training over winter on vitamin D metabolism, in adults with overweight/obesity.

Detailed description

Thirty adults with overweight/obesity (both males and females) who will meet the inclusion criteria will be randomly assigned to either an Exercise group (n=15) or a Control group (n=15). The Exercise group will participate in three hybrid-type high-intensity interval training sessions per week over a 12-week period, while receiving a balanced diet. The Control group will receive a balanced diet but will not participate in exercise training. Both groups will provide a resting blood sample and undergo assessment of their body composition (via bioelectrical impedance analysis), daily dietary intake (via dietary recalls) and physical activity level (via accelerometry) at baseline (prior to intervention), 6 weeks and 12 weeks.

Interventions

OTHERExercise training

Receive a balanced diet and participate in three hybrid-type high-intensity interval training sessions per week over a 12-week period

OTHERControl

Receive a balanced diet but abstain from any type of exercise training

Sponsors

University of Thessaly
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
35 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* BMI = 25-35 kg/m2 * Absence of musculoskeletal injuries * Absence of chronic health-related complications * Non-smokers

Exclusion criteria

* Consumption of Vitamin D supplements * Consumption of anti-inflammatory drugs, statins and/or steroids

Design outcomes

Primary

MeasureTime frameDescription
Change in 25-hydroxyvitamin D concentrationAt baseline, 6 weeks and 12 weeks25-OH-VD will be quantitatively determined in serum
Change in plasma Vitamin D binding protein concentrationAt baseline, 6 weeks and 12 weeksVitamin D binding protein concentration will be determined in plasma
Change in calcium concentrationAt baseline, 6 weeks and 12 weeksCalcium concentration will be determined in serum
Change in albumin concentrationAt baseline, 6 weeks and 12 weeksAlbumin concentration will be determined in serum
Change in aspartate aminotransferase (SGOT) concentrationAt baseline, 6 weeks and 12 weeksSGOT concentration will be determined in serum on a Clinical Chemistry analyzer
Change in alanine aminotransferase (SGPT) concentrationAt baseline, 6 weeks and 12 weeksSGPT concentration will be determined in serum on a Clinical Chemistry analyzer
Change in gamma-glutamyl transferase (γ-GT) concentrationAt baseline, 6 weeks and 12 weeksγ-GT concentration will be determined in serum on a Clinical Chemistry analyzer

Secondary

MeasureTime frameDescription
Change in reduced glutathione concentrationAt baseline, 6 weeks and 12 weeksReduced glutathione concentration will be determined in blood erythrocytes
Change in oxidized glutathione concentrationAt baseline, 6 weeks and 12 weeksOxidized glutathione concentration will be determined in blood erythrocytes
Change in dietary intakeAt baseline, 6 weeks and 12 weeksDietary intake habits will be assessed through dietary recalls
Change in physical activity levelAt baseline, 6 weeks and 12 weeksPhysical activity will be assessed via accelerometry
Change in body compositionAt baseline, 6 weeks and 12 weeksBody composistion will be assessed via bioelectrical impedance analysis (BIA)

Countries

Greece

Contacts

CONTACTDimitrios Draganidis, PhD
ddraganidis@uth.gr+302431047078
CONTACTIoannis G Fatouros, PhD
ifatouros@uth.gr2431047047
PRINCIPAL_INVESTIGATORDimitrios Draganidis, PhD

University of Thessaly

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 27, 2026